|
Latest Filings
|
View
|
Form
|
|
Filer
|
Received
|
Period
|
Download / Print
|
Actions
|
      |
10-K |
|
ACTUATE THERAPEUTICS, INC. |
03/13/25 |
12/31/24 |
|
|
  |
     |
8-K |
|
ACTUATE THERAPEUTICS, INC. |
02/07/25 |
02/07/25 |
|
|
  |
     |
8-K |
|
ACTUATE THERAPEUTICS, INC. |
12/17/24 |
12/17/24 |
|
|
  |
      |
10-Q |
|
ACTUATE THERAPEUTICS, INC. |
11/13/24 |
09/30/24 |
|
|
  |
     |
8-K |
|
ACTUATE THERAPEUTICS, INC. |
11/12/24 |
11/12/24 |
|
|
  |
      |
10-Q |
|
ACTUATE THERAPEUTICS, INC. |
09/24/24 |
06/30/24 |
|
|
  |
 |
SEC STAFF |
|
ACTUATE THERAPEUTICS, INC. |
09/10/24 |
|
|
|
  |
 |
SEC STAFF |
|
ACTUATE THERAPEUTICS, INC. |
09/10/24 |
|
|
|
  |
    |
4/A |
|
BP DIRECTORS, LP |
08/20/24 |
08/12/24 |
|
|
  |
    |
4/A |
|
BIOS ACTUATE CO-INVEST I, LP |
08/20/24 |
08/12/24 |
|
|
  |
|
|
|
Institutional Holders
|
|
Total Number of Holders
|
23
|
% of Shares Outstanding |
51.79%
|
Total Shares Held |
10,116,136
|
Total Value of Holdings |
$75,365,213.20
|
Net Activity |
9,733,969
|
|
|
|
Latest Company News
|
|
Date
|
|
|
|
|
(Quotes provided by Thomson Reuters are delayed by
15
minutes or more.)
|
|